BSE Live
Apr 02, 16:01Prev. Close
5.23
Open Price
5.79
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of DECIPHER LABS (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -5.03 | -1.66 | -2.66 | 11.27 | 1.39 | |
| Diluted EPS (Rs.) | -5.03 | -1.66 | -2.66 | 11.27 | 1.39 | |
| Cash EPS (Rs.) | -4.56 | -1.21 | -2.23 | 12.13 | 2.20 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 22.63 | 21.64 | 22.98 | 23.93 | 13.55 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 22.63 | 21.64 | 22.98 | 23.93 | 13.55 | |
| Revenue from Operations/Share (Rs.) | 22.39 | 35.52 | 45.12 | 64.68 | 55.01 | |
| PBDIT/Share (Rs.) | -5.85 | -0.54 | -1.05 | 13.56 | 4.06 | |
| PBIT/Share (Rs.) | -6.32 | -0.98 | -1.48 | 12.71 | 3.24 | |
| PBT/Share (Rs.) | -6.32 | -1.20 | -4.12 | 12.23 | 2.12 | |
| Net Profit/Share (Rs.) | -5.03 | -1.66 | -2.66 | 11.27 | 1.39 | |
| NP After MI And SOA / Share (Rs.) | -5.03 | -1.66 | -2.66 | 11.27 | 1.39 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -26.13 | -1.50 | -2.33 | 20.97 | 7.37 | |
| PBIT Margin (%) | -28.24 | -2.76 | -3.27 | 19.64 | 5.89 | |
| PBT Margin (%) | -28.24 | -3.37 | -9.12 | 18.91 | 3.85 | |
| Net Profit Margin (%) | -22.46 | -4.67 | -5.88 | 17.42 | 2.52 | |
| NP After MI And SOA Margin (%) | -22.46 | -4.67 | -5.88 | 17.42 | 2.52 | |
| Return on Networth/Equity (%) | -22.22 | -7.66 | -11.55 | 47.10 | 10.24 | |
| Return on Capital Employed (%) | -27.94 | -4.54 | -6.17 | 41.60 | 15.30 | |
| Return on Assets (%) | -19.71 | -4.98 | -9.52 | 27.13 | 3.62 | |
| Total Debt/Equity (X) | 0.01 | 0.00 | 0.04 | 0.43 | 0.64 | |
| Asset Turnover Ratio (%) | 0.76 | 1.16 | 1.30 | 0.04 | 143.49 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 7.24 | 2.10 | 5.01 | 3.44 | 1.30 | |
| Quick Ratio (X) | 7.24 | 2.10 | 5.01 | 3.44 | 1.30 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 1,257.06 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | -- | -2.49 | -2.49 | 28.74 | 2.89 | |
| Interest Coverage Ratios (Post Tax) (%) | -- | -2.49 | -2.49 | 28.74 | 2.89 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 8.05 | 5.60 | 7.86 | 48.39 | 35.56 | |
| EV/Net Operating Revenue (X) | 0.36 | 0.16 | 0.17 | 0.74 | 0.64 | |
| EV/EBITDA (X) | -1.36 | -10.36 | -7.39 | 3.53 | 8.68 | |
| MarketCap/Net Operating Revenue (X) | 0.47 | 0.42 | 0.31 | 0.82 | 0.61 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.46 | 0.68 | 0.62 | 2.21 | 2.47 | |
| Price/Net Operating Revenue | 0.47 | 0.42 | 0.31 | 0.82 | 0.61 | |
| Earnings Yield | -0.48 | -0.11 | -0.19 | 0.21 | 0.04 |
26.11.2025
DECIPHER LABS Consolidated September 2025 Net Sales at Rs 4.31 crore, down 26.47% Y-o-Y
24.11.2025
DECIPHER LABS Standalone September 2025 Net Sales at Rs 0.09 crore, up 5.01% Y-o-Y
10.06.2025
DECIPHER LABS Standalone March 2025 Net Sales at Rs 0.23 crore, down 93.27% Y-o-Y
03.06.2025
DECIPHER LABS Consolidated March 2025 Net Sales at Rs 3.50 crore, down 66.95% Y-o-Y
26.11.2025
DECIPHER LABS Consolidated September 2025 Net Sales at Rs 4.31 crore, down 26.47% Y-o-Y
24.11.2025
DECIPHER LABS Standalone September 2025 Net Sales at Rs 0.09 crore, up 5.01% Y-o-Y
10.06.2025
DECIPHER LABS Standalone March 2025 Net Sales at Rs 0.23 crore, down 93.27% Y-o-Y
03.06.2025
DECIPHER LABS Consolidated March 2025 Net Sales at Rs 3.50 crore, down 66.95% Y-o-Y
02.04.2026
02.04.2026
Lupin shares down 2% as arm to acquire 43.38% stake in Multicare Pharma
02.04.2026
02.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth